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Summary 
Expansion of mature neutrophils has been observed in mice lacking the murine interleukin 
(IL)  8  receptor homolog [mlL-8Rh(-/-)],  and human  (hu)  IL-8 suppresses proliferation of 
primitive myeloid cells in vitro and in vivo. To evaluate involvement and relevance of murine 
IL-8 receptor homolog (mIL-8Rh) in negative regulation of myelopoiesis, we studied mlL- 
8Rh(-/-)  and (+/+)  mice raised in a normal or germ-free environment. Immature myeloid 
progenitors from mlL-8Rh(+/+)  mice bred under normal or germ-free conditions were sig- 
nificantly  suppressed  in  vitro  by  recombinant  hulL-8,  macrophage  inflammatory  protein 
(MIP)-loL, platelet factor (PF)  4, interferon inducible protein  (IP)  10,  monocyte chemotactic 
peptide (MCP)  1, and H-ferritin. In contrast, progenitors from mlL-8Rh(-/-)  mice were in- 
sensitive to inhibition by IL-8, but not to these other chemokines and H-ferritin:-Mouse.MIP-2,  . 
a  ligand  for mlL-8Rh,  suppressed progenitors  from normal but  not  mlL-8Rh(-/-)  mice. 
Under  normal  environmental  conditions,  enhanced  numbers  of myeloid  progenitors  were 
found in femur, spleen, and blood ofmlL-8Rh(-/-)  compared with mlL-8Rh(+/+)  mice. 
Numbers ofmyeloid progenitors were greatly decreased in mlL-8Rh(-/-)  and (+/+)  mice in 
germ-free  conditions,  and  were  either  not  significantly  enhanced  in  mlL-8Rh(-/-)  mice 
compared with (+/+)  mice or were only moderately so. Differences in progenitors/organ be- 
tween a germ-free and normal environment were greater for the mlL-8Rh(-/-)  mice. These 
results document selective insensitivity ofmyeloid progenitor cells from mIL-8Rh(-/-)  mice 
to inhibition  by huIL-8 and mouse MIP-2 and a large expansion of myeloid progenitors in 
these mice, the latter effect being environmentally inducible. This provides strong support for a 
negative myelold regulatory role played by the mlL-8Rh in vivo, whose active ligand may be 
MIP-2. 
I 
L-8 is a member of the C-X-C subfamily of small mo- 
lecular weight inducible heparin-binding proteins (1, 2). 
Members of this family have been implicated in a number 
of activities associated with attraction and activation of leu- 
kocytes with postulated roles as mediators of inflammation 
(1, 3, 4). 
Two high-affinity human (hu) 1 IL-8 receptors have been 
cloned  and  characterized  (5-8),  whereas  the  murine  ge- 
tAbbreviations used in  this paper: BFU-E, erythrold progenitors; CFU- 
GEMM, mulupotential progenitors; CFU-GM, granulocyte-macrophage 
progenitors; FBS, fetal bovine serum; hu,  human; MCP,  rnonocyte 
chemotacnc peptlde; rnlL-8Rh, munne IL-8 receptor hornolog; MIP, 
rnacrophage rnflamrnatory protern; PF,  platelet factor; PWMSCM, 
pokeweed rnltogen mouse spleen cell condlnoned rnedlurn; rmu, recom- 
binant munne; SLF, steel factor. 
nome contains a single gene for the putative IL-8 receptor 
(9,  10).  Although  neither  mouse  nor  rat  IL-8  has  been 
identified  (11,  12),  antibodies  to  hulL-8  inhibit  lung  in- 
flammation in rats (13),  suggesting the presence of a mole- 
cule in rodents similar to IL-8. 
A  murine  gene  with  close  homology  to  two  known 
huIL-8 receptors was cloned, and homologous recombina- 
tion in embryonic stem cells was used to create mice that 
lacked the murine IL-8 receptor homolog (mlL-8Rh)  (9). 
Interestingly, expansion of neutrophilic myeloid and B lym- 
phoid  cells  was  apparent  in  mlL-8Rh(-/-)  mice.  In- 
creased numbers of these hematopoietic cells were noted in 
lymph nodes, spleen, bone marrow, and in the circulating 
blood.  Changes  in  these  phenotypes  were  not  detected 
with advanced age up to 20 wk, and heterozygous  [mlL- 
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Neutrophils from mlL-8P,.h(-/-)  mice were  as effective 
as those from mlL-8P,  h(+/+)  mice at intracellular and ex- 
tracellular killing of bacteria and at migration in vitro to a 
chemotactic and activating agent. However, neutrophils from 
mlL-8Rh(-/-)  mice did not migrate to ligands identified 
for this receptor: hulL-8 or mouse macrophage inflamma- 
tory protein  (MIP)  2  (9,  10).  It was  suggested from  these 
studies that the mlL-8P,  h  might be involved in the negative 
regulation  of neutrophil  production  (9).  The  concept  of 
mlL-8Rh being involved in negative regulation ofmyeloid 
blood  cells  is  consistent  with  the  suppressive  effects  of 
hulL-8 on immature subsets of human myeloid progenitor 
cells in  vitro  (14-17)  and  on  these  cells in vivo in mice 
(16,  17). 
This study was undertaken to more definitively evaluate 
a  role for the mlL-8R.h in negative regulation of myeloid 
blood cell production.  The  mechanism  of neutrophilia in 
mlL-8Rh(-/-)  mice  has  not  been  determined  (9).  This 
increase could have  originated from enhanced numbers  of 
hematopoietic  stem  or  myeloid progenitor  cells  that  es- 
caped negative regulation. Alternatively, this increase may 
have reflected enhanced proliferative capacity of precursor 
cells  such  as  myeloblasts,  promyelocytes,  or  myelocytes, 
and/or  increased  survival  and  migration  of  neutrophils. 
Based on our previous work (14-17), we chose to concen- 
trate  on  the level of myeloid progenitor cells. Progenitor 
cells from  mlL-8Rh(-/-)  and  (+/+)  mice,  bred under 
normal conditions (9)  or in a germ-free enwronment  (18), 
were  compared for responsiveness in  vitro  to  suppression 
by hulL-8, as well as to the effects of other chemokines and 
a  nonchemokine  suppressor  cytokine.  Additionally, abso- 
lute numbers  of myeloid progenitors in the bone marrow, 
spleen, and circulating blood of these mice were  enumer- 
ated. 
Materials  and Methods 
Mice.  mlL-8Rh(-/-)  BALB/c  mice  were  created  as  de- 
scribed elsewhere by deleung a murine gene with a high degree 
of homology to the two known hulL-8 receptors by homologous 
recombinanon (9). mIL-8Rh(-/-)  and control mIL-8Rh(+ / +) 
mine were bred under either normal environmental (9) or germ- 
free (18)  conditions. BDF  1 and C3H/HeJ  mice were purchased 
from The Jackson Laboratory (Bar Harbor, ME). Cells were ob- 
tained from  femoral  marrow,  spleen,  or  circulating peripheral 
blood of these mice (16,  17, 19, 20). 
Cytokines and Reagents.  rhu Epo was purchased from Amgen 
Biologicals (Thousand Oaks,  CA).  Heroin was  purchased from 
Eastman Kodak Co. (Rochester, NY). Pokeweed mitogen mouse 
spleen  cell  conditioned  medium  (PWMSCM),  a  source  of 
growth factors was prepared as described elsewhere (20). Punfied 
preparations of rhuIL-8, platelet factor (PF) 4, monocyte chemo- 
tactic peptide 1  (MCP-1),  and R.ANTES were purchased from 
Pepro  Tech  (Rocky Hills, NJ).  Purified rhuMIP-lot,  r  munne 
(rmu)  MIP-I~,  rmuMIP-2,  and  rhuMIP-2[3  were  purchased 
from R&D Systems, Inc. (Minneapolis, MN). Purified rhuGRO-o~ 
and rmu steel factor (SLF) were kind gifts from Immunex Corp. 
(Seattle, WA). Purified rhulP-10  was  purified as described (21) 
and was a kind gift from Andreas Sarris  (MD Anderson Cancer 
Center,  Houston,  TX).  Purified  rhuH-ferritin  was  a  kind gif~ 
from Dr. Paolo Arosio (University of  Milan, Milan, Italy) (22). 
Colony Assay.  Cells from bone marrow,  spleen and peripheral 
blood of mlL-8Rh(+/+)  and (-/-)  mice were plated, respec- 
tively, at 5-10  ×  104, 5 X  105, and 105 cells/ml in 35-ram tissue 
culture dishes (Coming Inc., Coming, NY)  m  1% methylcellu- 
lose culture medium with 30% fetal bovine serum (FBS; Hyclone 
Laboratories Inc., Logan, UT) in the presence of Epo (1  U/ml), 
10% vol/vol PWMSCM and 0.1  mM herren (17,  19).  Colonies 
deriving  from  granulocyte-macrophage  (CFU-GM),  erythroid 
(BFU-E),  and  mulnpotential  (CFU-GEMM)  progenitors were 
scored after 7 d of incubation in a humidified environment in an 
N2-O2-CO 2 incubator (model BNP-210;  Taboi ESPEC  Corp., 
South Plainfield, NJ)  at 5% CO2 and 5% 02. Absolute numbers 
of progenitors per organ were calculated based on the number of 
viable unseparated nucleated cells  per femur  or spleen and  the 
number of viable low-denmy (<1.077 gm/cm  3) penpheral blood 
cells retrieved after density cut separation using Ficoll-Hypaque 
(Pharmacla Fine Chemicals, Plscataway, NJ).  For assessment  of 
the  responsiveness of progenitors to  suppressmn  by  cytokines, 
bone marrow cells were plated as above m  methylcellulose cul- 
ture  medium  with  Epo,  PWMSCM,  and  heroin  (+50  ng/ml 
rmuSLF) or in 0.3% agar culture medium with  10% FBS in the 
presence of 100  U/ml rmuGM-CSF plus 50  ng/ml rmuSLF, in 
the presence of control diluent (PBS) or 100 ng/ml oflL-8, PF4, 
IP-10, MIP-hx, MCP-1,  or 10 -~ M  H-ferritin or varying con- 
centratmns ofrmumlP-2. These concentrations have been previ- 
ously determined to yield plateau levels of suppression under the 
growth factor condlnons described above. Although complete in- 
hibition of total colony formation is not seen, the decreases reflect 
complete inhibition of the enhanced growth noted when two or 
more growth factors are used to stimulate colony formation com- 
pared with a smgle growth factor (14, 15, 21, 23). Statistically  sig- 
nificant differences were determined by Student's t test. 
Results 
Responsiveness of Myeloid  Progenitor Cells to Negative Regu- 
lation.  We  first  assessed  whether  the  neutrophilia  ob- 
served  in  mlL-SR.h(-/-)  mice  might  result,  at  least  in 
part, from insensitivity to negative regulation at the level of 
myeloid progenitor cells. To  this end,  bone  marrow pro- 
genitor  cells  responsive  to  stimulation  by  multiple  cyto- 
kines (PWMSCM for CFU-GM  and Epo plus PWMSCM 
for BFU-E and CFU-GEMM)  were evaluated for their ca- 
pacxty to be suppressed in vitro by IL-8 and other members 
of the  chemokine  family previously shown  to  be  myelo- 
suppressive  (14-17,  21,  23,  24).  Myeloid  progenitor  cells 
from femurs of mlL-8Rh(+ / +) mice were significantly sup- 
pressed by IL-8, PF4, IP-10, MIP-lc~, and MCP-1, whether 
these cells derived from mice raised under normal environ- 
mental  (Fig.  1)  or germ-free  (Fig. 2)  conditions. Suppres- 
sion was also evident with H-ferritin, an iron-binding pro- 
tein with demonstrated myelosuppressive activity (22). The 
levels of suppression  seen  were  similar to  that  previously 
detected  with  chemokines  for  marrow  progenitors  from 
other strains of mice  (16,  17,  23).  In contrast,  CFU-GM, 
BFU-E,  and  CFU-GEMM  from  mlL-8Rh(-/-)  mice 
were insensitive to suppression by IL-8, whereas these pro- 
genitors did respond normally to inhibition by PF4, IP-10, 
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Figure  1.  Influence  of  sup- 
press]ve cytokmes on colony for- 
mation  by  myelold  progenitor 
cells from the femoral bone mar- 
row  of  mlL-8Rh(+/+)  and 
mlL-SR.h(-/-) mice raised un- 
der normal environmental con&- 
nons  Marrow cells were pooled 
from rather mght mlL-8Rh(+/+) 
or  mght mlL-8Rh(-/-)  rmce 
before plating m  sermsohd me- 
dram with Epo, PWMSCM, and 
heroin m the presence of control 
medmm  (saline) or  100  ng/ml 
rhu  preparanons  of IL-8,  PF4, 
IP-10,  MIP-la,  or MCP-1,  or 
10 -~ M rhuH-ferntm  Results are 
expressed as mean +-  1 SEM for 
l()  s marrow cells/ml  *Designates 
significant change from  control 
medium,  P <0.001;  other  val- 
ues are not slgmficant, P >0.05. 
MIP-lc~, MCP-1,  and  H-ferritin (Figs.  1  and  2).  Because 
progenitors  from  mlL-8P,  h(-/-)  mice  were  selectively 
insensitive to inhibition by a known ligand for this receptor, 
hulL-8, but did respond to ligands for other receptors, the 
results are consistent with the posmlanon that the mlL-SR.h 
is  involved in  negative  regulation  of myeloid progenitor 
cells. 
Because IL-8 has not been identified in mice (11,  12), we 
evaluated whether rmuMIP-2, a known ligand for mIL-8Rh, 
had  suppressive  activity. As  shown  in  Fig.  3,  rmuMIP-2 
had myeloid progenitor cell suppressive activity compara- 
ble to that ofmuMIP-loL, rhuIL-8, and rhuPF4 on marrow 
cells from  BDF 1 and  C3H/HeJ  mice.  The  dose-response 
suppression by rmuMIP-2 was comparable to that of other 
suppressive  chemokines  (14,  17,  23,  24).  Three  chemo- 
kines previously reported by us to lack suppressive activity 
(rhuRANTES,  GRO-ot, and MIP-213)  (17, 24) were inac- 
tive in these  assays (Fig. 3).  Additionally, rmuMIP-2  (100 
ng/ml)  significantly suppressed colony formation by bone 
marrow CFU-GM,  BFU-E, and CFU-GEMM  from mlL- 
81<h(+/+),  but not from mlL-8Rh(-/-)  mice, with re- 
spective  decreases  in  two  experiments  of 46-47,  34-41, 
and  49-50%  for  (+/+)  CFU-GM,  BFU-E,  and  CFU- 
GEMM  (P  <0.001).  Effects  of  rmuMIP-2  on  (-/-) 
CFU-GM,  BFU-E, and CFU-GEMM  ranged from  -4  to 
+3% of control numbers  (P >0.05). 
Quantitation  of Myeloid  Progenitor Cells in Mice.  We next 
evaluated whether  lack of responsiveness  of marrow  cells 
from mlL-8Rh(-/-)  mice in vitro to a known ligand for 
this receptor, as shown  above, translated into an increased 
absolute number of myeloid progenitor cells in these mice. 
The  absolute number  of myeloid progenitor cells in mar- 
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Figure  2.  Influence  of  sup- 
presslve cytokmes on colony for- 
matlon  by  myeloid  progemtor 
cells from the femoral bone  mar- 
row ofmlL-8Rh(+ / + ) and mlL- 
8Rh(-/-)  nnce bred and raised 
under germ-free condmons. Mar- 
row cells were pooled from ra- 
ther  four  mlL-8Rh(+/+)  or 
eight mIL-8Rh(-/--) mice before 
plating  m  seml-solM medium as 
m  Fig.  1.  Colony formauon by 
BFU-E and  CFU-GEMM were 
combined  because  of the  rela- 
tively  low  numbers  of  CFU- 
GEMM  colomes in  this  set  of 
experiments.  Results  are  ex- 
pressed  as  mean  +  1  SEM  for 
105 marrow cells/rnl. *Designates 
slgmficant  change  from  control 
mechum, P <0.001,  other values 
are not slgmlficant, P >0.05. 
row  (femur),  spleen,  and  blood  of mlL-8Rh(-/-)  and 
(+/+)  mice raised under normal environmental conditions 
were determined  (Table  1). Absolute numbers  of CFU-GM 
and  CFU-GEMM  in  the marrow and  CFU-GM,  BFU-E, 
and  CFU-GEMM  in  the  spleen  and  blood  were  signifi- 
cantly higher in the mlL-8Rh(-/-)  compared with (+/+) 
mice.  The  largest  differences  between  progenitors  in  the 
(-/-)  and  (+/+)  mice  were  noted  in  spleen  and  blood 
and for CFU-GEMM  in these organs. 
Hematopoiesis  is  greatly  influenced  by  environmental 
stresses  such  as bacteria  and bacterial products  (25),  and be- 
cause members of the chemokine family are inducible pro- 
teins  whose production  can be  enhanced  by such  types  of 
environmental triggers  (1, 3, 4), we also compared absolute 
numbers  of myeloid progenitors from both  mlL-8Rh(+  / +) 
and (-/-)  mice raised under germ-free conditions (Table 2). 
The  absolute  numbers  of  myeloid  progenitors  in  mlL- 
8Rh(+/+)  mice were significantly (P <0.001)  reduced  in 
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Figure  3.  ComparaUve influence of 
rmuMIP-2  on  colony  formation  m 
vitro by myelold progemtor  cells from 
femoral  bone  marrow.  Results  are 
shown as mean -+ SD for three separate 
experiments (one using BDF  1 cells  and 
two using C3H/HeJ cells), a,  Stgmfi- 
cant  change  from  control  diluent, 
P <0.01; b, P <0.05. 
1828  IL-8 Receptor and Negative Regulation of Myelopoiesis In Vlvo Table  1.  Comparative Analysis of Marrow,  Spleen,  and Peripheral Blood Cellularity and Myetoid Progenitors  from mlL-8Rh(+ /+) 
and mlL-Rh(-/-)  Mice Raised under Normal Environmental Conditions 
mlL-8Rh cells  Nucleated cellularity  CFU-GM  BFU-E  CFU-GEMM 
x  10 -6/femur or spleen cells 
or 1 ml of blood 
X  10 -s/femur or spleen cells 
or 1 mI of blood 
Femoral bone marrow 
(+/+)  15.5  _  1.3  23.3  _+  1.8  4,4  +  0.3  1,1  +  0.1 
(-/-)  18,9  +  0.9  45.2  +  3.8*  4.4  +  0.4  1.6  +  0.1" 
Fold A of(-/-)  compared with (+/+)  1,22  1.94  1.0  1.45 
Spleen 
(+/+)  68.6  ___  8.0  6.3  +  1.1  2.6  ___ 0.5  0.2  +  0.1 
(-/-)  99.1  ___  18.2"  31.4  ___  7.3*  10.2  +  3.0*  2.4  +  0.7* 
Fold A of(--/--) compared with (+/+)  1,44  4.98  3.92  12,0 
Peripheral blood 
(+/+)  4.I  +  0.5  35.4  2  5.6  26.0  +  6.2  0 
(-/-)  11.0  +  4.9*  283.9  ___ 97,8*  49,6  4-  819"  7,4  +  2,5" 
Fold A of(-/-)  compared with (+/+)  2.68  8.0  1.91  >74.0 
Results shown are an average of eight mice per group expressed as mean  _+  1 SEM with each mouse assessed individually. Colony assays were done 
m methylcellulose with Epo. PWMSCM, and hemin. 
*Sigmficant change compared with mlL-8Rh (+/+),  P <0.05. 
mice  raised  under  germ-free  compared  with  normal  envi- 
ronmental  conditions  (compare  Tables  2  and  1).  Under 
germ-free  conditions  there  were  similar  absolute  numbers 
of BFU-E  and  CFU-GEMM  in  marrow  and  CFU-GM, 
BFU-E,  and  CFU-GEMM  in  spleen  and  blood  for  mlL- 
8Rh(-/-)  and (+/+)  mice (Table 2). A  significant increase 
was seen in CFU-GM  in marrow between mlL-8Rh(-/-) 
and  (+ ! +)  mice  raised under  germ-free  conditions  (Table 
2),  but this  difference was less than that seen in mice raised 
under normal environmental  conditions  (compare Tables 2 
Table 2.  Comparative Analysis of Marrow,  Spleen,  and Peripheral Blood Cellularity and Myeloid Progenitors  from mlL-8Rh(+ /+) 
and mlL-8Rh(-/-)  Mice Raised under Germ-Free Conditions 
mlL-8Rh cells  Nucleated cellularity  CFU-GM  BFU-E  CFU-GEMM 
X  1  O- 6~femur or spleen cells 
or 1 ml of blood 
X  10 -3~femur or spleen cells 
or I ml of blood 
Femoral bone marrow 
(+/+)  13.4  _+  0,3  8.2  ___ 0.5  2.3  +  0.5  0.3  +  0 
(-/-)  14,6  +_  0.5  11.4  +  0.7*  3.1  4- 0.4  0.3  +  0.1 
Fold A of (-/-)  compared with (+/+)  1.09  1.39  1.35  1,0 
Spleen 
(+/+)  59,2  4-  2.1  1.5  +  0.2  2,8  _+  0.3  0.18  +  0.003 
(-/-)  56,2  +  3.3  2.2  +  0.4  2.5  4-  0.3  0.13  +  0.001 
Fold A of (-/-)  compared with (+/+)  0,95  1.47  0.89  0.72 
Peripheral Blood 
(+/+)  0.71  4-  0.1  19.8  +  8.8  38,0  +  19.1  0 
(-/-)  0.36  +  0.07*  8.5  ___  4.5  3,3  +  1.6  0 
Fold A of (-/-)  compared with (+ / +)  0.5  0.43  0,09  0 
Results are an average of four mlL-8Rh(+/+) and mght mlL-8Rh(-/-)  mice per group expressed as mean +  1 SEM with each mouse assessed m- 
&vidually. Colony assays were done exactly as m Table 1. 
*  Significant  change compared with mlL-8Rh(+ / +). 
1829  Broxmeyer et al. and 1). Moreover, and of special interest, calculation of the 
fold changes in progenitors per organ from a germ-free to 
normal  environment  (Tables  2  and  1)  demonstrated  that 
the  largest  differences  were  noted  for  (-/-)  compared 
with  (+/+)  mice.  The fold changes from a germ free to 
normal environment were for (-/-)  versus (+/+)  mice: 
bone marrow CFU-GM, 4.0 versus 2.8; spleen CFU-GM, 
14.3  versus  4.2;  peripheral  blood  CFU-GM,  33.4  versus 
1.8;  bone marrow BFU-E,  0.7 versus  1.9:  spleen BFU-E, 
1.4  versus  0.9;  peripheral blood BFU-E,  15.0  versus 0.7; 
bone marrow CFU-GEMM,  5.3 versus 3.7;  spleen CFU- 
GEMM,  18.5  versus  1.1;  peripheral blood CFU-GEMM, 
>74.0  versus  no  change  (no  colonies  in  either  group). 
Thus,  except  for bone  marrow BFU-E,  the  fold  change 
was always greater for the  (-/-)  compared with  (+/+) 
mice. 
Taken  together,  the  results  demonstrate  that  mlL- 
8P,.h(-/-)  mice have a hyperplasia of myeloid progenitor 
cells compared with the control mlL-81<h(+/+) mice, but 
this increase is environmentally influenced, and greater dif- 
ferences  from  a  germ-free  to  normal  environment  are 
noted for (-/-)  compared with (+/+)  mice. 
Discussion 
Hematopolesls is regulated by both positive and negative 
factors (26-28).  A  number of cytokines have been impli- 
cated in negative regulation (29,  30). These suppressive cy- 
tokines include  members of the chemokine family of pro- 
teins with c-x-c motifs such as IL-8, PF-4, IP-10, ENA78, 
and MIP-2cx (= GRO-[3), and members with c-c moti£ such 
as  MIP-lot,  MCP-],  and  MIP-related  protein  (MRP)  1 
and 2  (14-17,  19, 21, 23, 24, 31).  These chemokines have 
direct suppressive activity in vitro on primitive hematopoi- 
etic  cells  including  the  immature  subsets  of  CFU-GM, 
BFU-E,  and CFU-GEMM that are stimulated to prolifer- 
ate  by  combinations  of cytokines  such  as  GM-CSF  plus 
SLF for CFU-GM and Epo plus SLF with or without IL-3 
for BFU-E  and  CFU-GEMM.  Chemokines are also sup- 
pressive  for  myeloid  progenitors  stimulated  by  multiple 
cytokines present in  conditioned  medium such as PWM- 
SCM. Members of the chemokine family without suppressive 
activity include  those with a c-x-c motif such as MIP-213 
(=GRO-y),  GRO-cl,  and  NAP-2  and  those  with  a  c-c 
motif such  as  MIP-I[3  and  RANTES  (14,  17,  23,  24). 
None of the tested chemokines had suppressive activity in 
vitro for the more mature myeloid progenitors stimulated 
to proliferate by a single cytokine. Evidence for an in vivo 
role for suppressive chemokines and their receptors has thus 
far come from studies in which  administration  of chemo- 
kines  to  mice resulted in  myelosuppression.  Chemokines, 
including  IL-8, found to be suppressive in vitro were also 
suppressive in vivo. These effects were dose dependent, time 
related,  and reversible (16,  17,  19).  Chemokines not sup- 
pressive in vitro were inactive in these effects in vivo. 
The generation ofmlL-8P,.h(-/-) mice, in which neu- 
trophilia  was  present  (9),  offered  us  the  opportunity  to 
evaluate whether  the  mIL-8R.h was  involved in  negative 
1830  IL-8 Receptor and Negative 
regulation at the level of myeloid progenitor cells.  The re- 
sults  clearly  demonstrate  that  myeloid  progenitors  from 
mlL-8Rh(-/-)  mice  have  a  selective  defect  in  respon- 
siveness in vitro to negative regulation by hulL-8, a ligand 
for the mlL-8Ikh (9,  10).  Consistent with this lack of re- 
sponsiveness, a hyperplasia of myeloid progenitors in mar- 
row, spleen, and circulating blood was noted in these mice. 
The neutrophilia noted in mlL-8Rh(-/-)  mice can thus 
probably be completely or mostly explained based on en- 
hancement in numbers of CFU-GM and CFU-GEMM in 
these mice, although it is possible that other effects might 
be involved. Erythroid  hyperplasia has not been noted in 
mlL-8Rh(-/-)  mice,  even  though  increased  levels  of 
BFU-E  have  been  detected  in  the  spleen  and  blood  of 
these mice. This might reflect a level of ineffective erythro- 
poiesis wherein increased erythroid progenitors do not, un- 
der  the  normal  environmental  conditions  in  which  these 
mice have been  raised,  give  rise  to  increased  erythrocyte 
numbers. Our studies were not meant to address the mech- 
anism of B lymphocyte increases in mlL-8Rh(-/-)  mice. 
These increases might reflect increased levels of B lympho- 
cyte progenitors and/or a common myeloid/B lymphocyte 
progenitor cell. 
Because  a  murine  homologue  of hulL-8  has  not  been 
identified  (11,  12)  it  remained  to  be  determined  which 
ligand or ligands for the mlL-8Rh might function as an in 
vivo modulator of negative regulation. Besides hulL-8, two 
murine chemokines, MIP-2 and KC, have been shown to 
trigger a  signal  through  the  mIL-8Rh  (9,  10).  However, 
GlkO-ot, considered to he human counterpart of mKC, is 
not myelosuppressive in vitro or in vivo (14,  17),  although 
huGRO-ot,  as well as huMIP-2[3  (=  GRO-y), can block 
the in vitro suppressive effects of hulL-8  on human mye- 
loid progenitors (14).  Our studies herein demonstrating the 
myeloid progenitor cell-suppressing effect of rmuMIP-2 in 
vitro on normal progenitors, but not the progenitors from 
mlL-81q.h(-/-)  mice,  suggests  that  muMIP-2  might  be 
the suppressive chemoklne for the mlL-8Rh in vivo. We 
had previously not found  muMIP-2  to be myelosuppres- 
sive in vitro (24),  but those former studies were done be- 
fore the potent costimulating cytokine SLF was used to en- 
hance the sensitivity of our suppressor assays. 
There is presently little information regarding intracellu- 
lar  signaling  in  myeloid progenitors  by  chemokines,  and 
these studies, of necessity, have used growth factor-depen- 
dent cell lines so that enough  cells  of a particular type are 
available. Whereas human preparations of IL-8, PF4, MIP- 
lci, and IP-10 suppress proliferation of myeloid growth fac- 
tor-dependent cell line M07e, the intracellular mechanisms 
of MIP-lot and IP-10, which act through a cAMP depen- 
dent protein kinase A  Raf-1  kinase pathway, are different 
from those  of IL-8 and  PF4,  which  do not influence  this 
pathway (32).  Thus, how hulL-8 signals  through a hulL-8 
receptor to  elicit  a  negative proliferative effect is  not yet 
known.  However,  based  on  knowledge  of the  mlL-8Rh 
compared with human  IL-8RA (=CXC1K1)  and IL-8Rd3 
(= CXC1K2), it would appear that the rhulL-8 is mediating 
its suppressive effects through the IL-8RB. 
Regulanon  of Myelopolesls In Vlvo Chemokines  are  usually  not  constitutively  present  in 
much, if any, significant quantity, unless their production is 
induced. Thus, the relevance of a mlL-8Rh and ligand in- 
teraction  involving  negative  regulation  would  probably 
make most sense in the context of an environmentally in- 
duced  stress  possible under  normal  environmental  condi- 
tions, but would be less likely under germ-free conditions. 
That  numbers  of myeloid  progenitors  were  significantly 
decreased in control mice raised under germ-free compared 
with those control mice raised under normal environmen- 
tal conditions is consistent with the need for environmen- 
tally induced stress for enhanced myeloid cell proliferation. 
The fact that little or no differences were found in absolute 
numbers  of progenitors between the mlL-8P,  h(-/-)  and 
(+/+)  mice  raised  under  germ-free  conditions  enhances 
the  relevance  of our  findings  and  strongly implicates in- 
volvement  of mlL-8Rh  and  a  ligand for  this  receptor in 
negative regulation at the progenitor cell level. This is es- 
pecially so because we detected much greater enhancement 
in  progenitor  cell  numbers  when  mlL-8Rh(-/-)  com- 
pared  with  mlL-8Rh(+/+)  mice  were  evaluated  in  a 
germ-free to a normal environment, hulL-8 has direct sup- 
pressive effects on  myeloid progenitors in vitro as assessed 
on purified preparations ofCD34 ÷ cells (14) and single iso- 
lated CD34 ÷++  cells (15); however, whether the effects in 
vivo of the suppressive murine ligand(s) for the mlL-8Rh 
acts  directly on  the progenitors and/or indirectly through 
an accessory mediated effect remains to be determined. 
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